Segall Bryant & Hamill LLC Acquires 18,839 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Segall Bryant & Hamill LLC boosted its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 21.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 106,421 shares of the medical device company's stock after purchasing an additional 18,839 shares during the quarter. Segall Bryant & Hamill LLC owned approximately 0.05% of Cooper Companies worth $11,742,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the business. Envestnet Portfolio Solutions Inc. grew its position in shares of Cooper Companies by 43.1% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 35,233 shares of the medical device company's stock worth $3,076,000 after acquiring an additional 10,616 shares during the last quarter. Axxcess Wealth Management LLC increased its stake in shares of Cooper Companies by 298.4% in the first quarter. Axxcess Wealth Management LLC now owns 8,211 shares of the medical device company's stock valued at $833,000 after purchasing an additional 6,150 shares during the period. Public Employees Retirement Association of Colorado raised its holdings in shares of Cooper Companies by 298.9% during the first quarter. Public Employees Retirement Association of Colorado now owns 245,793 shares of the medical device company's stock valued at $24,938,000 after buying an additional 184,171 shares during the last quarter. Diversify Advisory Services LLC acquired a new position in shares of Cooper Companies during the second quarter worth approximately $501,000. Finally, BDF Gestion bought a new position in Cooper Companies in the 2nd quarter worth approximately $2,919,000. Institutional investors own 24.39% of the company's stock.

Cooper Companies Trading Up 0.0 %

NASDAQ:COO opened at $99.08 on Thursday. The stock has a fifty day simple moving average of $106.29 and a 200 day simple moving average of $98.19. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $19.73 billion, a price-to-earnings ratio of 55.20, a price-to-earnings-growth ratio of 2.14 and a beta of 0.99. The Cooper Companies, Inc. has a 1-year low of $82.21 and a 1-year high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.91 by $0.05. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The business had revenue of $1 billion for the quarter, compared to analyst estimates of $997.30 million. During the same quarter in the previous year, the business earned $0.84 earnings per share. The firm's revenue was up 7.8% compared to the same quarter last year. Sell-side analysts forecast that The Cooper Companies, Inc. will post 3.65 earnings per share for the current year.

Insider Transactions at Cooper Companies

In related news, CFO Brian G. Andrews sold 24,788 shares of the business's stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the transaction, the chief financial officer now directly owns 6,614 shares of the company's stock, valued at approximately $700,422.60. The trade was a 78.94 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Daniel G. Mcbride sold 114,992 shares of the stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total transaction of $12,129,356.16. Following the completion of the sale, the chief operating officer now owns 44,696 shares of the company's stock, valued at approximately $4,714,534.08. The trade was a 72.01 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 256,373 shares of company stock valued at $27,637,427 over the last quarter. Company insiders own 2.00% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. Stifel Nicolaus reiterated a "buy" rating and set a $115.00 price target (up previously from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. StockNews.com lowered shares of Cooper Companies from a "buy" rating to a "hold" rating in a research report on Wednesday. Piper Sandler boosted their price target on shares of Cooper Companies from $115.00 to $120.00 and gave the stock an "overweight" rating in a research report on Thursday, August 29th. Morgan Stanley increased their price objective on shares of Cooper Companies from $95.00 to $104.00 and gave the company an "equal weight" rating in a report on Tuesday, September 10th. Finally, Robert W. Baird raised their price objective on shares of Cooper Companies from $118.00 to $125.00 and gave the company an "outperform" rating in a research note on Thursday, August 29th. Four equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $117.00.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.